Acumen Pharmaceuticals ABOS
NASDAQ ABOS
$2.06 +0.03 (+1.48%)
At close: Oct 22, 2026 · 4:00 PM EDT

Acumen Pharmaceuticals (ABOS) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Acumen Pharmaceuticals (ABOS) posted Return on Capital Employed [ROCE] of -135.20% for Q2 2026, down 47.05 percentage points from -88.16% a year earlier and down 19.44 percentage points from the prior quarter.

Analysis

Acumen Pharmaceuticals (ABOS) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Acumen Pharmaceuticals' Return on Capital Employed [ROCE] came in at -82.06%, down 35.89 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has declined for four consecutive years, with a four-year change of -67.25 percentage points (FY2021 to FY2025).
  • In prior years, Acumen Pharmaceuticals' Return on Capital Employed [ROCE] was -46.17% in FY2024 (-20.74 pp), -25.43% in FY2023 (-3.44 pp), -22.00% in FY2022 (-7.19 pp) and -14.81% in FY2021.
  • The Q2 2026 figure stands as the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q4 2021.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has declined in each of the last eight quarters, with an average year-over-year change of -47.23 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q1 2024, with a gain of 4.66 percentage points; the weakest was Q4 2025, with a drop of 70.20 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -115.77% (Q1 2026), -120.79% (Q4 2025) and -102.31% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 17.52%
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 17.92%
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 6.28%
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 19.32%
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 16.76%
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 16.66%
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -5.97%
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 11.86%
10 Acumen Pharmaceuticals 148.97 Mn -333.10 Mn - -135.20%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -135.20%
Mar 31, 2026 -115.77%
Dec 31, 2025 -120.79%
Sep 30, 2025 -102.31%
Jun 30, 2025 -88.16%
Mar 31, 2025 -62.55%
Dec 31, 2024 -50.59%
Sep 30, 2024 -36.01%
Jun 30, 2024 -27.43%
Mar 31, 2024 -22.14%
Dec 31, 2023 -21.43%
Sep 30, 2023 -25.20%
Jun 30, 2023 -30.00%
Mar 31, 2023 -26.80%
Dec 31, 2022 -23.55%
Sep 30, 2022 -19.62%
Jun 30, 2022 -15.17%
Mar 31, 2022 -11.30%
Dec 31, 2021 -8.61%
API Access

Acumen Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ABOS&period=max&api_key=YOUR_API_KEY